Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chambers

Showing results (451-460 of 466) with videos related to

Pageof 47
Sort By:
Cancer Research|September 22, 2021
EGFR Inhibition Enhances the Cellular Uptake and Antitumor-Activity of the HER3 Antibody-Drug Conjugate HER3-DXdHeidi M Haikala, Timothy Lopez, Jens Köhler, et al.
Nature Immunology|April 2, 2020
Sestrins induce natural killer function in senescent-like CD8<sup>+</sup> T cellsBranca I Pereira, Roel P H De Maeyer, Luciana P Covre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2018
Amplification of Wild-type <i>KRAS</i> Imparts Resistance to Crizotinib in <i>MET</i> Exon 14 Mutant Non-Small Cell Lung CancerMagda Bahcall, Mark M Awad, Lynette M Sholl, et al.
Oral Oncology|June 14, 2025
Computed tomography radiomics-based cross-sectional detection of mandibular osteoradionecrosis in head and neck cancer survivorsSerageldin Kamel, Laia Humbert-Vidan, Zaphanlene Kaffey, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 26, 2009
In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonistJohn R Atack, Karen A Maubach, Keith A Wafford, et al.
Aging Cell|January 6, 2025
Immunotherapeutic targeting of aging-associated isoDGR motif in chronic lung inflammationPazhanichamy Kalailingam, SoFong Cam Ngan, Ranjith Iyappan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 13, 2017
Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors, Mona Kamal, David I Rosenthal, et al.
International Journal of Particle Therapy|July 21, 2021
Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution ExperienceG Brandon Gunn, Adam S Garden, Rong Ye, et al.
Nature Cancer|April 19, 2022
Phosphate dysregulation via the XPR1-KIDINS220 protein complex is a therapeutic vulnerability in ovarian cancerDaniel P Bondeson, Brenton R Paolella, Adhana Asfaw, et al.
Nature Food|May 2, 2023
A natural mutation in Pisum sativum L. (pea) alters starch assembly and improves glucose homeostasis in humansKaterina Petropoulou, Louise J Salt, Cathrina H Edwards, et al.
Pageof 47

Showing results (451-460 of 466) with videos related to

Sort By:
Pageof 47
Cancer Research|September 22, 2021
EGFR Inhibition Enhances the Cellular Uptake and Antitumor-Activity of the HER3 Antibody-Drug Conjugate HER3-DXdHeidi M Haikala, Timothy Lopez, Jens Köhler, et al.
Nature Immunology|April 2, 2020
Sestrins induce natural killer function in senescent-like CD8<sup>+</sup> T cellsBranca I Pereira, Roel P H De Maeyer, Luciana P Covre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2018
Amplification of Wild-type <i>KRAS</i> Imparts Resistance to Crizotinib in <i>MET</i> Exon 14 Mutant Non-Small Cell Lung CancerMagda Bahcall, Mark M Awad, Lynette M Sholl, et al.
Oral Oncology|June 14, 2025
Computed tomography radiomics-based cross-sectional detection of mandibular osteoradionecrosis in head and neck cancer survivorsSerageldin Kamel, Laia Humbert-Vidan, Zaphanlene Kaffey, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 26, 2009
In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonistJohn R Atack, Karen A Maubach, Keith A Wafford, et al.
Aging Cell|January 6, 2025
Immunotherapeutic targeting of aging-associated isoDGR motif in chronic lung inflammationPazhanichamy Kalailingam, SoFong Cam Ngan, Ranjith Iyappan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 13, 2017
Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors, Mona Kamal, David I Rosenthal, et al.
International Journal of Particle Therapy|July 21, 2021
Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution ExperienceG Brandon Gunn, Adam S Garden, Rong Ye, et al.
Nature Cancer|April 19, 2022
Phosphate dysregulation via the XPR1-KIDINS220 protein complex is a therapeutic vulnerability in ovarian cancerDaniel P Bondeson, Brenton R Paolella, Adhana Asfaw, et al.
Nature Food|May 2, 2023
A natural mutation in Pisum sativum L. (pea) alters starch assembly and improves glucose homeostasis in humansKaterina Petropoulou, Louise J Salt, Cathrina H Edwards, et al.
Pageof 47